3 reasons why Indian pharma is getting ready for unstoppable growth

September 7, 2024

For Indian pharmaceutical companies, this scenario presents a distinct opportunity. Leveraging their established expertise and leadership in global COVID-19 vaccine distribution, along with robust supply chain efficiencies, Indian firms are strategically positioned to capitalize on this market shift. The departure of Chinese players from the market opens a significant gap, which Indian companies are well-equipped to fill .

More To Explore

NSE adds NBCC, Torrent Power, 4 more stocks into F&O segment. Contracts to trade from January 31

The NSE of India will include six new stocks in the Futures and Options segment from January 31, 2025. The stocks are Castrol India, Gland

January 7, 2025

Tech View: Nifty forms Inside Bar Candle, can correct below 23,600. How to trade on Wednesday

Technical indicators sent mixed signals on Tuesday, with the RSI at 43 indicating bearish momentum, while a bullish crossover in the Stochastic RSI hinted at

January 7, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003